A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats
Saved in:
| Main Authors: | Hidemichi Takai, Yoichi Sunagawa, Masafumi Funamoto, Kana Shimizu, Satoshi Shimizu, Yasufumi Katanasaka, Yusuke Miyazaki, Atsusi Imaizumi, Tadashi Hashimoto, Hiromichi Wada, Koji Hasegawa, Tatsuya Morimoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-12-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2021.16.PO13 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice
by: Yuto Kawase, et al.
Published: (2021-12-01) -
The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats
by: Yoichi Sunagawa, et al.
Published: (2021-12-01) -
Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
by: Masafumi Funamoto, et al.
Published: (2019-01-01) -
Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay
by: Satoshi Shimizu, et al.
Published: (2021-12-01) -
Chrysanthemum morifolium Extract Prevents the Development of Doxorubicin-induced Heart Failure
by: Masaya Ono, et al.
Published: (2021-12-01)